Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weijing Sun

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Cancer|October 11, 2013
Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancerChristine A Ciunci, Rodolfo F Perini, Anjali N Avadhani, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumorsRobert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
The Oncologist|June 6, 2026
Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): A phase II study (NIRA-PANC)Anup Kasi, Raed Moh'd Taiseer Al-Rajabi, Joaquina Celebre Baranda, et al.
Clinical Epigenetics|January 7, 2022
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysisChaoyuan Kuang, Yongseok Park, Ryan C Augustin, et al.
Cancer|August 2, 2018
Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinomaRandall Brand, Erkut Borazanci, Virginia Speare, et al.
Gastroenterology|December 2, 2019
Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in MicePrasad Dandawate, Gaurav Kaushik, Chandrayee Ghosh, et al.
JAMA Oncology|April 21, 2022
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell TransplantQamar J Khan, Cory R Bivona, Grace A Martin, et al.
JAMA Oncology|March 16, 2018
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 TrialCharles S Fuchs, Toshihiko Doi, Raymond W Jang, et al.
Cell Reports|September 8, 2021
Tumor-initiating stem cell shapes its microenvironment into an immunosuppressive barrier and pro-tumorigenic nicheXi He, Sarah E Smith, Shiyuan Chen, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Cancer|October 11, 2013
Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancerChristine A Ciunci, Rodolfo F Perini, Anjali N Avadhani, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumorsRobert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
The Oncologist|June 6, 2026
Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): A phase II study (NIRA-PANC)Anup Kasi, Raed Moh'd Taiseer Al-Rajabi, Joaquina Celebre Baranda, et al.
Clinical Epigenetics|January 7, 2022
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysisChaoyuan Kuang, Yongseok Park, Ryan C Augustin, et al.
Cancer|August 2, 2018
Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinomaRandall Brand, Erkut Borazanci, Virginia Speare, et al.
Gastroenterology|December 2, 2019
Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in MicePrasad Dandawate, Gaurav Kaushik, Chandrayee Ghosh, et al.
JAMA Oncology|April 21, 2022
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell TransplantQamar J Khan, Cory R Bivona, Grace A Martin, et al.
JAMA Oncology|March 16, 2018
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 TrialCharles S Fuchs, Toshihiko Doi, Raymond W Jang, et al.
Cell Reports|September 8, 2021
Tumor-initiating stem cell shapes its microenvironment into an immunosuppressive barrier and pro-tumorigenic nicheXi He, Sarah E Smith, Shiyuan Chen, et al.
Pageof 14